These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24470236)

  • 1. Structural evidence for a constrained conformation of short CDR-L3 in antibodies.
    Teplyakov A; Obmolova G; Malia TJ; Luo J; Gilliland GL
    Proteins; 2014 Aug; 82(8):1679-83. PubMed ID: 24470236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canonical structures of short CDR-L3 in antibodies.
    Teplyakov A; Gilliland GL
    Proteins; 2014 Aug; 82(8):1668-73. PubMed ID: 24623659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
    Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
    Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation of the hypervariable region L3 without the key proline residue.
    Guarné A; Bravo J; Calvo J; Lozano F; Vives J; Fita I
    Protein Sci; 1996 Jan; 5(1):167-9. PubMed ID: 8771210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies.
    Poulas K; Eliopoulos E; Vatzaki E; Navaza J; Kontou M; Oikonomakos N; Acharya KR; Tzartos SJ
    Eur J Biochem; 2001 Jul; 268(13):3685-93. PubMed ID: 11432734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain.
    Derrick JP; Maiden MC; Feavers IM
    J Mol Biol; 1999 Oct; 293(1):81-91. PubMed ID: 10512717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDR-H3 loop ensemble in solution - conformational selection upon antibody binding.
    Fernández-Quintero ML; Kraml J; Georges G; Liedl KR
    MAbs; 2019; 11(6):1077-1088. PubMed ID: 31148507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.
    Cheetham GM; Hale G; Waldmann H; Bloomer AC
    J Mol Biol; 1998 Nov; 284(1):85-99. PubMed ID: 9811544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of Fab hGR-2 F6, a competitive antagonist of the glucagon receptor.
    Wright LM; Brzozowski AM; Hubbard RE; Pike AC; Roberts SM; Skovgaard RN; Svendsen I; Vissing H; Bywater RP
    Acta Crystallogr D Biol Crystallogr; 2000 May; 56(Pt 5):573-80. PubMed ID: 10771426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of Fab fragment of malaria transmission blocking antibody 2A8 against P. vivax P25 protein.
    Saxena AK
    Int J Biol Macromol; 2012 Jan; 50(1):153-6. PubMed ID: 22037467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and humanization of a rat monoclonal Fab to human interleukin-5.
    Cook WJ; Walter LJ; Murgolo NJ; Chou CC; Petro M; Zavodny PJ; Narula SK; Ramanathan L; Trotta PP; Nagabhushan TL
    Protein Eng; 1996 Jul; 9(7):623-8. PubMed ID: 8844835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.